Results 211 to 220 of about 62,620 (348)

Liver transplantation for primary sclerosing cholangitis in the Nordic countries: Outcome after acceptance to the waiting list [PDF]

, 2003
B Brandsæter, Ulrika Broomé, Helena Isoniemi, Styrbjörn Friman, Bent Hansen, Erik Schrumpf, Antti Oksanen, Bo-Göran Ericzon, Krister Höckerstedt, Heikki Mäkisalo, Rolf Olsson, Michael Olausson, Preben Kirkegaard, Kristian Bjøro   +13 more
openalex   +1 more source

Inflammatory Bowel Disease Outcomes in Northern Iran: A Retrospective Cohort Study of Remission, Complications, and Treatment Strategies

BioMed Research International, Volume 2026, Issue 1, 2026.
Background Inflammatory bowel disease (IBD), encompassing Crohn′s disease (CD) and ulcerative colitis (UC), is a chronic inflammatory condition affecting the gastrointestinal tract. While significant progress has been made in managing IBD, the long‐term outcomes remain heterogeneous, prompting this cohort study.
Poria Hoseinialiabadi, Iradj Maleki, Hafez Fakheri, Mahboobe Ebrahimi, Elham Yousefi Abdolmaleki, Tarang Taghvaei, Hajar Shokri-Afra, Baisakhi Banerjee   +7 more
wiley   +1 more source

Burden of primary sclerosing cholangitis in Sweden (2002-2020): Incidence, outcomes, healthcare utilization, and costs. [PDF]

Hepatol Commun
Bergquist A, Kachru N, Aldvén M, Ström O, Skröder H, Toresson Grip E, Hagström H.   +6 more
europepmc   +1 more source

Association between serum IgG level and clinical course in primary sclerosing cholangitis [PDF]

, 2019
Theresa Hippchen, Peter Sauer, Benjamin Göppert, Peter Schirmacher, Daniel Gotthardt, Karl-Heinz Weiss, Wolfgang Stremmel, C Rupp   +7 more
openalex   +1 more source

Pyoderma Gangrenosum as the First Manifestation of Inflammatory Bowel Disease: A Case Report

Case Reports in Gastrointestinal Medicine, Volume 2026, Issue 1, 2026.
Approximately 50% of patients with inflammatory bowel disease (IBD) exhibit extraintestinal manifestations, among which skin and mucosal lesions are common. However, pyoderma gangrenosum occurs in only 1%‐2% of IBD patients. We report the case of a 23‐year‐old male patient who was admitted to the hospital with pyoderma gangrenosum that was unresponsive
Nam Hoai Nguyen, Tan Thi Tran, Trang Thu Khuc, Yen Thi Lo, Ha Thi-Ngoc Doan, Hieu Van Nguyen, Long Cong Nguyen, Marcel Cc Machado   +7 more
wiley   +1 more source

Association of Primary Sclerosing Cholangitis With HLA-C*07:02 in a Japanese Population. [PDF]

Liver Int
Okamoto T, Okajima H, Kadohisa M, Yamamoto M, Uebayashi EY, Okumura S, Sakamoto K, Ito T, Hatano E.   +8 more
europepmc   +1 more source

Impact of Diverse Clinical Characteristics on Survival Benefit of Liver Transplantation

Journal of Transplantation, Volume 2026, Issue 1, 2026.
Background Liver transplantation (LT) is offered as a life‐saving treatment to those with end‐stage liver disease. There has recently been much interest in considering the survival benefit of transplant when prioritizing patients for transplant. In this study, we aimed to measure the survival benefit of LT across various patient demographics by ...
Mouaid Alim, Bishoy Lawendy, Shiyi Chen, Naomi Khaing Than Hlaing, Saba Maleki, Mamatha Bhat, Zachary Fricker   +6 more
wiley   +1 more source

Hepatic Stem/Progenitor Cell Activation Differs between Primary Sclerosing and Primary Biliary Cholangitis [PDF]

, 2017
Guido Carpino, Vincenzo Cardinale, Trine Folseraas, Diletta Overi, Annarosa Floreani, Antonio Franchitto, Paolo Onori, Nora Cazzagon, P.B. Berloco, Tom H. Karlsen, Domenico Alvaro, Eugenio Gaudio   +11 more
openalex   +1 more source

RIPK1 inhibition reduces biliary injury and fibrosis in primary sclerosing cholangitis. [PDF]

Sci Adv
Soret PA, Steunou V, Hedou J, Tokgozoglu J, Pistorio V, Majdi A, Darwane N, Delaunay JL, Benyahia S, Dinard L, Ledent T, Metatla I, Guerrera C, Lhomme M, Ponnaiah M, Galon J, Soussan P, Serfaty L, Corpechot C, Housset C, Aït-Slimane T, Verdonk F, Chazouillères O, Wendum D, Ratziu V, Lemoinne S, Cadoret A, Chignard N, Gautheron J.   +28 more
europepmc   +1 more source

Primary sclerosing cholangitis: a narrative review of diagnostic and prognostic biomarkers. [PDF]

Transl Gastroenterol Hepatol
Rolfes PS, de Zoeten EF, Forman L, Mack CL.   +3 more
europepmc   +1 more source